BamSEC and AlphaSense Join Forces
Learn More

Glaxosmithkline Capital Inc

Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.3
from F-3ASR 31 pages Underwriting Agreement Among Glaxosmithkline Capital PLC as Issuer GSK Plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.2
from F-3ASR 32 pages Underwriting Agreement Among Glaxosmithkline Capital Inc. as Issuer GSK Plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.1
from F-3ASR 31 pages Underwriting Agreement Between GSK Plc as Issuer and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.3
from POS AM 30 pages Underwriting Agreement Among Glaxosmithkline Capital PLC as Issuer GSK Plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.2
from POS AM 30 pages Underwriting Agreement Among Glaxosmithkline Capital Inc. as Issuer GSK Plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.1
from POS AM 29 pages Underwriting Agreement Between GSK Plc as Issuer and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.8
from 8-A12B 10 pages Glaxosmithkline Capital Inc. 3.875% Notes Due 2028 Fully and Unconditionally Guaranteed by Glaxosmithkline plc
12/34/56
EX-1.7
from 8-A12B 10 pages Glaxosmithkline Capital Inc. 3.625% Notes Due 2025 Fully and Unconditionally Guaranteed by Glaxosmithkline plc
12/34/56
EX-1.6
from 8-A12B 10 pages Glaxosmithkline Capital Inc. 3.375% Notes Due 2023 Fully and Unconditionally Guaranteed by Glaxosmithkline plc
12/34/56
EX-1.3
from F-3ASR 48 pages Underwriting Agreement Among Glaxosmithkline Capital PLC as Issuer Glaxosmithkline plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.2
from F-3ASR 50 pages Underwriting Agreement Among Glaxosmithkline Capital Inc. as Issuer Glaxosmithkline plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.1
from F-3ASR 47 pages Underwriting Agreement Between Glaxosmithkline plc as Issuer and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.3
from F-3 46 pages Underwriting Agreement Among Glaxosmithkline Capital PLC as Issuer Glaxosmithkline plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.2
from F-3 48 pages Underwriting Agreement Among Glaxosmithkline Capital Inc. as Issuer Glaxosmithkline plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.1
from F-3 45 pages Underwriting Agreement Between Glaxosmithkline plc as Issuer and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.3
from F-3ASR 48 pages Glaxosmithkline Capital PLC [ ] Notes Due 20[ ] Fully and Unconditionally Guaranteed by Glaxosmithkline plc Underwriting Agreement
12/34/56
EX-1.2
from F-3ASR 50 pages Underwriting Agreement Among Glaxosmithkline Capital Inc. as Issuer Glaxosmithkline plc as Guarantor and [ ] as Representatives of the Underwriters Dated as of [ ], 20[ ]
12/34/56
EX-1.1
from F-3ASR 47 pages Glaxosmithkline PLC [ ] Notes Due 20[ ] Underwriting Agreement
12/34/56
EX-1.5
from 8-A12B 11 pages Glaxosmithkline Capital Inc. 4.200% Notes Due 2043 Fully and Unconditionally Guaranteed by Glaxosmithkline plc
12/34/56
EX-1.4
from 8-A12B 11 pages Glaxosmithkline Capital Inc. 2.800% Notes Due 2023 Fully and Unconditionally Guaranteed by Glaxosmithkline plc
12/34/56